[Form 4] Under Armour, Inc. Insider Trading Activity
Under Armour director Robert John Sweeney purchased 100,000 shares of Class C common stock on 08/21/2025 at a weighted average price of $4.882 per share, increasing his beneficial holdings to 133,695.8 shares. The transaction was executed in multiple trades at prices ranging from $4.865 to $4.890; the filing notes the reporting person will provide detailed trade-level information upon request. The Form 4 was signed by Mehri F. Shadman as attorney-in-fact for Mr. Sweeney. The filing also states that no Class A common stock (UAA) is beneficially owned.
- Director purchase disclosed: Robert John Sweeney acquired 100,000 Class C shares, increasing beneficial ownership to 133,695.8 shares.
- Transparent execution details: Filing discloses trade price range ($4.865–$4.890) and weighted average price ($4.882), with offer to provide full trade-level information upon request.
- None.
Insights
TL;DR: Director purchase of 100,000 Class C shares at ~$4.88 signals an insider buy, though size relative to company float is unspecified.
The filing documents a single-day acquisition of 100,000 Class C common shares by Director Robert John Sweeney on 08/21/2025 at a weighted average price of $4.882 per share, executed across multiple trades between $4.865 and $4.890. Beneficial ownership after the transaction is reported as 133,695.8 shares. The disclosure is routine under Section 16 and was executed via attorney-in-fact; no derivative transactions or Class A holdings were reported. For investors, the primary observable fact is the insider purchase; the filing does not provide context on proportionate ownership, intent, or impact on control.
TL;DR: Standard Section 16 disclosure of a director purchase; procedural details (attorney-in-fact, multiple trades) are noted.
The Form 4 shows compliance with insider reporting requirements: the reporting person is a director, the form is filed by one reporting person, and the signature was provided by an attorney-in-fact. The explanation clarifies execution in multiple trades and offers to supply trade-level details on request. The filing also explicitly states absence of Class A common stock holdings. No changes to board composition, grants, or derivative positions are disclosed.